Clinical Study Results
What happened during the study?
Before the participants took the study drug, the doctors checked to make
sure they could join the study. The doctors:
• did a physical examination
• took blood and urine samples
• checked the participants’ heart health using an electrocardiogram, also
called an ECG
• asked the participants about their medical history, how they were feeling,
and what medicines they were taking
During the study, the participants visited their study site 1 time and stayed at the
site for 8 days. On 5 of these days, the participants took AB/FF through an inhaler.
The participants took AB/FF 2 times a day for 4 days in a row. On Day 5, they took
AB/FF 1 time.
The AB/FF doses were measured in micrograms, also called μg. Each AB dose
was 400 μg, and each FF dose was 12 μg.
Throughout the study, the doctors took blood and urine samples. They also
checked the participants’ overall health.
At the end of the study, the participants visited their study site 1 more time so
the doctors could check their health and ask them how they were feeling.
The chart below shows how the study was done.
Before taking During the At the end of
the study drug study the study
1 visit 1 visit 1 visit
• The doctors checked to • The participants stayed at • The doctors checked the
make sure the participants their study site for 8 days health of the participants
could join the study
• The participants took
AB/FF for 5 days in a row
up to 7 days after
up to 3 weeks 8 days
the last dose
3